XML 31 R19.htm IDEA: XBRL DOCUMENT

STOCKHOLDERS' EQUITY

3 Months Ended

Mar. 31, 2019

Stockholders' Equity Note [Abstract]

STOCKHOLDERS' EQUITY

12. STOCKHOLDERS’ EQUITY

Common Stock

The Company had 8,726,045 shares of common stock, $0.001 par value per share, outstanding as of March 31, 2019 and December 31, 2018.

Stock-Based Compensation

A summary of stock option activity under the 2011 Long-Term Incentive Plan as of March 31, 2019, and changes during the three months ended March 31, 2019, are presented below:

			Stock Options				Weighted average exercise price				Weighted average remaining contractual term				Aggregate intrinsic value
Outstanding as of January 1, 2019				424,800			$	8.30				6.5			$	22
Granted				—				—
Exercised				—				—
Forfeited				—				—
Outstanding as of March 31, 2019				424,800			$	8.30				6.20			$	16
Exercisable as of March 31, 2019				414,467			$	8.35				6.20			$	16

As of March 31, 2019, there were 248,867 shares available for future grants under the Company’s 2011 Long-Term Incentive Plan.

Stock-based compensation expense recorded for the three months ended March 31, 2019 and 2018 was approximately $5 and $148, respectively. At March 31, 2019, the Company had total stock-based compensation expense remaining to be recognized in the consolidated statements of operations of approximately $8.

Foreign Currency Translation

Foreign assets and liabilities are translated using the exchange rate in effect at the balance sheet date, and results of operations are translated using an average rate for the period. Translation adjustments are accumulated and reported as a component of accumulated other comprehensive income (loss). The Company had foreign currency translation adjustments resulting in unrealized loss of $312 and $166 for the three months ended March 31, 2019 and 2018, respectively.